Shanghai Xiao Fang Pharmaceutical Co., Ltd.SSE: 603207

Announcement on Implementation of Dividend Distribution for 2025

Jun 26, 2026 · Issued by Shanghai Xiao Fang Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 26, 2026

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-907

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shanghai Xiao Fang Pharmaceutical Co., Ltd. on 6ix

Earlier from Shanghai Xiao Fang Pharmaceutical

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive PlanJun 25
Announcement on Redemption of Partial Temporarily Idle Raised Funds Used for Cash ManagementJun 24
Announcement on Resolutions of the 11th Meeting of the 2nd Board of DirectorsJun 11
Announcement on Lifting Sales Restrictions and Listing for Circulation in the 1st Restriction Lifting Period for the 1st Grant under 2025 Restricted Stock Incentive PlanJun 9
Announcement on Convening Performance Briefing for 2025 and Q1 2026Jun 3

Later from Shanghai Xiao Fang Pharmaceutical

Announcement on the 1st Granting of Restricted Stocks to Incentive Objects in 2026 Restricted Stock Incentive PlanJun 30
Announcement on the Resignation of the Independent DirectorsJul 2
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual ReportJul 15
Announcement on Election of Independent DirectorsJul 23
Announcement on Completion of Industrial and Commercial Registration ChangeAug 8

All Shanghai Xiao Fang Pharmaceutical news releases

Follow Shanghai Xiao Fang Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai Xiao Fang Pharmaceutical